Comorbidity in social anxiety disorder: diagnostic and therapeutic challenges
Drugs in Context2019Vol. 8, pp. 1–13
Citations Over TimeTop 1% of 2019 papers
Abstract
Comorbid disorders are highly prevalent in patients with social anxiety disorder, occurring in as many as 90% of patients. The presence of comorbidity may affect the course of the disease in several ways such as comorbidity in patients with social anxiety disorder (SAD) is related to earlier treatment-seeking behavior, increased symptom severity, treatment resistance and decreased functioning. Moreover, comorbidities cause significant difficulties in nosology and diagnosis, and may cause treatment challenges. In this review, major psychiatric comorbidities that can be encountered over the course of SAD as well as comorbidity associated diagnostic and therapeutic challenges will be discussed.
Related Papers
- → Post-traumatic stress disorder as a comorbidity: impact on disease outcomes(2012)47 cited
- → 2.65 Prevalence and Comorbidity Patterns of Psychiatric Classifications in a Large Child and Adolescent Psychiatric Sample (N = 71,119)(2022)1 cited
- → Comorbidity in Child Psychiatric Diagnosis(2014)1 cited
- → Psychiatric Comorbidity in Alcoholism: Importance of Ascertainment Source(1991)20 cited
- → S151. Investigating the Genetic Architecture of Psychiatric Disorders and Their Medical Comorbidity(2019)